Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000694914 | SCV000823380 | uncertain significance | Baller-Gerold syndrome | 2024-11-27 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1120 of the RECQL4 protein (p.Glu1120Lys). This variant is present in population databases (rs776023102, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 573280). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000765999 | SCV000897431 | uncertain significance | Baller-Gerold syndrome; Rapadilino syndrome; Rothmund-Thomson syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing |